Navigation Links
Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate

CAMBRIDGE, Mass., June 18, 2007 /PRNewswire-FirstCall/ -- Genzyme Corp. today announced the results of two new studies comparing a powder form of Renvela (sevelamer carbonate) to Renagel tablets (sevelamer hydrochloride), including one trial in which patients received the powder form three times per day, and one in which it was administered once per day.

Genzyme is developing Renvela in powder form to provide an additional option for patients with chronic kidney disease in managing their phosphate levels. A New Drug Application for Renvela tablets is already on file with the FDA, and previous studies have shown that the tablet formulation provides equivalent phosphate control to Renagel in patients on dialysis and significant phosphorus control in patients with chronic kidney disease who are not on dialysis. Today's results are the first from trials comparing the efficacy of the powder form of Renvela to Renagel tablets.

In the first powder trial, patients treated with the powder form of Renvela three times per day experienced equivalent phosphorus control to patients treated with Renagel tablets three times per day. As a result, this trial successfully met its primary endpoint.

In the second trial, patients dosed with the powder form of Renvela once per day and those treated with Renagel tablets three times per day achieved statistically significant reductions in serum phosphorus, with both groups reaching target levels for phosphorus control outlined in the K/DOQI treatment guidelines. Phosphorus levels in the Renagel arm (4.6 mg/dL) were lower than those in the Renvela arm (5.3 mg/dL), and this trial did not achieve its primary endpoint of demonstrating non-inferiority of Renvela powder dosed once per day to Renagel tablets dosed three times per day.

In both trials, the safety profile of Renvela was consistent with the previous clinical experience of patients on dialysis using Ren
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/3/2015)... WEST JORDAN, Utah , Aug. 3, 2015  BC ... Solutions has acquired Ohio Valley Medical Systems, one of ... MRI systems.  The addition of Ohio Valley Medical Systems ... to now include Hitachi MRI.   "We ... Mark Alvarez , President and CEO of BC Technical. ...
(Date:8/3/2015)... MINNEAPOLIS , Aug. 3, 2015 ... become a significant shareholder and will become the ... Solutions for cardiology-related diagnostic and monitoring offerings. ... milestone for Preventice Solutions," said Jon Otterstatter ... CEO, Preventice Solutions.  "We are thrilled to partner ...
(Date:8/3/2015)... ROSEMONT, Ill. , Aug. 3, 2015 ... ankle problem, and you,re looking for the best possible ... for the best outcome too, and now there,s a ... there. Following steps recommended by the American Orthopaedic ... after surgery can help you avoid complications and heal ...
Breaking Medicine Technology:BC Technical Acquires Ohio Valley Medical Systems 2Boston Scientific Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions 2Patient Guide: How to Prepare for Surgery 2
... Eli Lilly and Company,(NYSE: LLY ) has ... Quality Assurance (NCQA) for its Tools that Empower(TM),Depression ... Care Management Program is designed,for managed care organizations ... care around Major Depressive Disorder (MDD). Lilly created ...
... compared with cold dissection ... ... surgical device company, today announced that a study published in,the Annals ... Tissue Welding Technology in total tonsillectomy,patients resulted in significantly less intraoperative ...
Cached Medicine Technology:Lilly Receives NCQA Design Certification for Depression Care Management Program 2Lilly Receives NCQA Design Certification for Depression Care Management Program 3Study Finds Starion Instruments' Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients 2
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Angelina Jolie ... that affects millions of women every year. Dr. Angela DeRosa, DO, MBA, CPE ... hormone replacement therapies, takes the scary unknown out of menopause. , Myth #1: ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... States, Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August ... save lives," Dr. Carmona said. "I strongly believe in the mission of the ...
(Date:8/4/2015)... Dublin, Ohio (PRWEB) , ... August 04, 2015 , ... ... days of summer in the sun and preparing for the back-to-school scramble. Dublin, ... of summer is the best time for the annual dental checkup. In fact, the ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... Kingdom and other international locations have shown a rise in binge drinking among ... link between binge drinking and depression, are continuing to examine trends and evidence ...
(Date:8/4/2015)... Horeb, WI (PRWEB) , ... August 04, 2015 , ... ... released video on the subject, Renew Man™ is standing up as a voice of ... 15-year veteran of the healthy aging industry with special experience and expertise in the ...
Breaking Medicine News(10 mins):Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3
... , ... in online-based medical transcription, has tapped Randy Olver as its new CEO, effective immediately. ... (Vocus) November 5, 2009 -- ... its new CEO, effective immediately., , , , ,Emdat’s founding partners, who remain actively involved ...
... VOLC ), a leader in the development, manufacture and ... and peripheral artery disease, today reported revenues of $53.9 million ... for the quarter ended September 30, 2009, represent an increase ... third quarter of 2008. Revenues for the third quarter of ...
... 5 STINSON Brand Innovation is offering a custom e-book, "Notes on ... 8-14. , The e-book is one in a series of e-books titled ... on C la s ... no charge at http://www.stinsonbrandinnovation.com/ebooks/SBI_NotesOnNursing.htm , "This is a way we ...
... human genomes could be sequenced next year, company says , ... says it has developed a lower-cost DNA platforming sequence. ... full human genomes, was published Nov. 5 in Science ... cost for three genomic DNA nanoarrays ranged from $1,726 to ...
... A drug already approved for the treatment of lymphoma may ... in children and teens, according to an early-stage study published ... The study drug, Bortezomib, was found to be effective against ... While key experiments were in animals, the cancer studied closely ...
... -- Picture it: One jerk in a bar spends the ... of the evening, the women aren,t receptive to even the ... in evolutionary theory. Males increase their fitness by acquiring more ... and therein lies the conflict. Researchers at Binghamton ...
Cached Medicine News:Health News:Randy Olver Named Emdat CEO, Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 2Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 2Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 3Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 4Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 5Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 6Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 7Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 8Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 9Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 10Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 11Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 12Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 13Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 14Health News:National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of 'Notes on Nursing' e-book 2Health News:Approved lymphoma drug shows promise in early tests against bone cancer 2Health News:Mom was right: Nice guys don't always finish last 2
... is specifically designed to work with the ... is a small tank blotter that incorporates ... (low buffer requirements and fast transfer rates), ... semi-dry blotting such as arcing and buffer ...
... Blot Module allows you to easily transfer proteins ... fits neatly into the XCell SureLock and XCell ... assembly. It requires less than 200 ml of ... Tough platinized titanium and stainless steel electrodes create ...
... The GENIE is the proven electrophoretic ... the ultimate in field uniformity. Its design ... the electrodes which, when coupled with a ... battery charger, creates a high field in ...
Semi-Dry Blotting Unit for 10 x 10cm Gels...
Medicine Products: